Consider joining this study.
If you have high blood pressure, diabetes and cardiovascular disease, this clinical study could be a good fit for you. While lifestyle changes and current medicines offer some protection, many people with these conditions still experience disease progression that increases their risk of further cardiovascular complications and kidney damage. That's why we're running a global clinical study called EASi-PROTKT™ that aims to find out whether combining an investigational medicine with an approved medicine called empagliflozin could help people reduce their risk of developing serious heart health events, including heart failure, in the future.
Click below to see if you qualify!
